Welcome to Journal Watch. The content you requested requires sign in with a username and password.
UVA-1 for Sclerotic Skin Disease: More Is Not Better
A moderate approach balances the therapeutic efficacy of enough UVA-1 exposure against the tanning effects of too much exposure, which can block its benefits.
Sign In
Don't yet have a username or password?
Register now for
Journal Watch e-mail alerts and unlimited online
access to articles 6 months after publication.
Subscribe now for
Full, immediate online access to all Journal Watch content and services.
Already a subscriber? Activate your subscription to receive full online access.
Get full site access with a 7-day site pass for $19